Summary
As even small premature babies have functional nociceptive systems and can show unwanted, or even dangerous, stress responses, the best possible treatment of pain and best sedation should be guaranteed in paediatric and neonatal intensive care medicine. It has been shown in one study that providing the particular physiological features of children are adequately taken into account, narcotic analgesics can be highly appropriate for this purpose. Children who are adequately treated with analgesics and sedatives make better progress, the hormonal stress reaction is at least attenuated and may not occur at all, and metabolic disasters do not occur to the same extent as is observed when no treatment for relief of pain is given. With respect to the particular features of the physiology in childhood, it must be born in mind that:
-
1.
Resorption can be faster, especially after intramuscular injection.
-
2.
In view of the smaller pool capacity and the higher unbound fraction in the plasma than in the adult, a larger effective fraction must be assumed on distribution of the drugs given.
-
3.
Metabolism in the liver and excretion by the kidneys will proceed with some delay during the first 3–6 months of life.
Care must be taken to see that the circulation is stable and hypovolaemia is not present, as neonates in particular can respond to the administration of sedatives and/or analgesics with a drop in blood pressure.
Morphine and fentanyl are particularly suitable for use for analgo-sedation in artificially ventilated preterm and full-term neonates; owing to its shorter duration of action and good controllability fentanyl has advantages over morphine.
When additional sedation is necessary, pentobarbitone can be given in this group of patients as a short-term infusion, in a single dose of 2–3 mg/kg body weight. When adequate analgo-sedation is achieved with this combination, artificial ventilation of preterm and full-term neonates is well tolerated. The infants’ own respiratory impulsion, which can be prejudicial to mechanical respiration, is largely suppressed, and the consumption of other analgesics, sedatives and catecholamines is decisively lower. When infants undergo sedation with barbiturates alone, without analgesic medication, as is quite common, the heart rate and blood pressure are not different from after administration of fentanyl; in the first 3 days of treatment the mean blood pressure is even somewhat with fentanyl. Analgo-sedation with fentanyl also has drawbacks, however: elevation of the bilirubin value and delayed elimination of meconium.
A combination of fentanyl and midazolam is suitable for analgo-sedation in infants being mechanically ventilated. Care must be taken to ensure that when both are infused simultaneously the dose of midazolam is smaller.
In addition to the broad spectrum of pharmacological treatments, it is important that particular attention be given to the provision of a quiet environment and that to minimize fear and stress, contact between the children and their parents be encouraged, which is perfectly well possible even during mechanical ventilation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Anand KJS, Hickey PR (1987) Pain and its effect in the human neonate and fetus. N Engl J Med 317: 1321–1329
Anand KJS, Brown MJ, Bloom SR, Aynsley-Green A (1985) Studies on the hormonal regulation of glucose metabolism in the human newborn infant undergoing anaesthesia and surgery. Horm Res 22: 115–128
Anand KJS, Brown MJ, Canson RC et al (1985) Can the human neonate mount an endocrine and metabolic response to surgery? J Pediatr Surg 20: 41–84
Anand KJS, Sippell WG, Aynsley-Green A (1987) Randomized trial of fentanyl anesthesia in preterm babies undergoing surgery: effects on the stress response. Lancet 1: 62–65
Anand KJS, Sippell WG, Schofield NM, Aynsley-Green A (1988) Does halothane anesthesia decrease the metabolic and endocrine stress responses of newborn infants undergoing operation? Br Med J 296: 668–672
Fitzgerald M (1987) Pain and analgesia in neonates. Trends Neurosci 10: 344–346
Fitzgerald M, McIntosh N (1989) Pain and analgesia in the newborn. Arch Dis Child 64: 441–443
Fletcher AB (1987) Pain in the neonate. N Engl J Med 317: 1347–1348
Gauntlett IS (1987) Analgesia in the neonate. Br J Hosp Med 37: 518–519
Gladtke E (1970) Die Reifung von Stoffwechselfunktionen beim Neugeborenen. Med Welt 21: 1305–1313
Gladtke E (1971) Pharmakokinetik von Chemotherapeutica in Abhängigkeit vom Lebensalter. Monatsschr Kinderheilk 119: 105–110
Gladtke E, Rind H (1965) Der Stoffwechsel als werdende Funktion beim Kind. Monatsschr Kinderheilk 113: 299–302
Hartwig S, Roth B, Theisohn M (1991) Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the pediatric intensive care unit. Eur J Pediatr 150: 784–788
Jacqz-Aigrain E, Wood C, Robieux I (1990) Pharmacokinetics of midazolam in critically ill neonates. Eur J Clin Pharmacol 39: 191–192
Kok THHG, Brown S, Single P (1985) Can a fetus feel pain? Br Med J 291: 1220–1221
Krebs R, Kersting F (1972) Zur Ursache der hämodynamischen Nebenwirkungen einiger Narkotica. Anaesthesist 21: 153–165
Lehmann KA (1990) Opiate in der Kinderanästhesie. Anaesthesist 39: 195–204
Lloyd-Thomas AR, Booker PD (1986) Infusion of midazolam in pediatric patients after cardiac surgery. Br J Anaesth 58: 1109–1115
McGrath PJ, Unruh AM (1987) Pain in children and adolescents. Pain Res Clin Management 1: 198–202
Noerr B (1990) Fentanyl citrate. Neonatal Network 9: 85–87
Olive G, Rey E (1982) Pharmacocinétique comparée des benzodiazépines. Nouv Presse Med 11: 2957–2964
Purcell-Jones G, Dormon F, Sumner E (1987) The use of opiods in neonates. A retrospective study of 933 cases. Anaesthesia 42: 1320–1323
Rana SR (1987) Pain: a subject ignored. Pediatrics 79: 309–310
Roth B (1989) Erfahrungen zur Analgesie und Sedierung in der pädiatrischen Intensivmedizin In: Stockhausen H-B v (Hrsg) Pädiatrische Intensivmedizin X. Thieme, Stuttgart New York, S 150–151
Roth B, Heimann G, Gladtke E (1977) D-Glukarsäureausscheidung bei Neugeborenen mit transitorischer Hyperbilirubinämie nach Phenobarbitalbehandlung. Pädiatr Pädol 12: 385–392
Shapiro C (1989) Pain in the neonate: assessment and intervention. Neonatal Network 8: 7–21
Taburet AM, Chamouard C, Aymard P, Chevalier JY, Costil J (1982) Phenobarbital protein binding in neonates. Develop Pharmacol Ther 4 [Suppl 1]: 129–134
Truog R, Anand KJS (1989) Management of pain in the postoperative neonate. Clin Perinatol 16: 61–78
Way WL, Trevor AJ (1986) Pharmacology of intravenous nonnarcotic anesthetics. In: Miller RD (ed) Anesthesia, 2nd edn. Churchill Livingstone, New York, p 806
Yaster M (1987) The dose response of fentanyl in neonatal anesthesia. Anesthesiology 66: 433–435
Yaster M, Deshpande JK (1988) Management of pediatric pain with opioid analgesics. J Pediatr 113: 421–429
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Schlünder, C. et al. (1993). Erfahrungen zur Analgosedierung in der pädiatrisch-neonatologischen Intensivmedizin. In: Meier, H., Kaiser, R., Moir, C.R. (eds) Schmerz beim Kind. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84898-8_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-84898-8_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56421-8
Online ISBN: 978-3-642-84898-8
eBook Packages: Springer Book Archive